CDK9-IN-15
CDK9-IN-15 (compound 50) is a potent CDK9 inhibitor[1].
Product Specifications
CAS Number
[852678-17-2]
UNSPSC
12352005
Hazard Statement
H315-H319
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-15.html
Purity
98.97
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC1=C2C=CC=C(NC3=C(C=CS4)C4=NC=N3)C2=CC=C1
Molecular Formula
C16H11N3OS
Molecular Weight
293.34
Precautions
P264-P280-P302+P352-P305+P351+P338-P362+P364
References & Citations
[1]Van Duyne R, et al. Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription. J Mol Biol. 2013;425 (4) :812-829.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147026/CDK9-IN-15-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147026/CDK9-IN-15-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Toxoplasma gondii Dense granule protein 6 (GRA6), partial
Recombinant Toxoplasma gondii Dense granule protein 6 (GRA6), partial
Recombinant Toxoplasma gondii Dense granule protein 6 (GRA6), partial